<bill session="119" type="h" number="88" updated="2025-02-11T22:16:06Z">
  <state datetime="2025-01-03">REFERRED</state>
  <status>
    <introduced datetime="2025-01-03"/>
  </status>
  <introduced datetime="2025-01-03"/>
  <titles>
    <title type="display">Medical Innovation Acceleration Act of 2025</title>
    <title type="short" as="introduced">Medical Innovation Acceleration Act of 2025</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001302"/>
  <cosponsors/>
  <actions>
    <action datetime="2025-01-03">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-01-03" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects/>
  <amendments/>
  <summary date="2025-02-11T22:15:38Z" status="Introduced in House">Medical Innovation Acceleration Act of 2025

This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.

The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.</summary>
</bill>
